Interwoven Nitinol Stents versus Drug Eluting Stents in the Femoro-Popliteal Segment: A Propensity Matched Analysis
Critical limb ischemia
Target lesion
Popliteal artery
DOI:
10.1016/j.ejvs.2019.06.012
Publication Date:
2019-09-06T21:23:01Z
AUTHORS (22)
ABSTRACT
BackgroundPercutaneous transluminal angioplasty (PTA) is a common procedure in patients with peripheral arterial disease (PAD) affecting the femoropopliteal segment (F-P). Biomimetic nitinol stents (Supera stent, SPS) and drug eluting (DES) were designed to improve longevity of F-P PTA; however, their performance has not been compared pragmatic setting, taking atherosclerotic plaque characteristics into account.MethodsOverall, 296 consecutive (mean age: 73 y, SD: 11 65% male, 68% chronic limb threatening ischaemia) who underwent PTA using SPS or DES between 2013 2018 identified from prospectively maintained institutional database. Patient characteristics, including characterisation based on computed tomography, collected; 121 case matched pairs created propensity score patient data.ResultsDuring median two year follow up, 28% cohort (32% vs. 24% DES, p = .07) developed target lesion restenosis (TLR) > 50%. Among patients, those significantly more likely develop TLR >50% (31% 27%, .34), stent occlusion (13% 12%, .85 – secondary patency rate 87% 88%), have major amputation (10% 6%, .16), require re-intervention (14% 9%, .12), die (7% vs.4%, .31). Plaque calcification did predict either group, both non populations. Multivariable analysis adjusted for revealed that main predictors at years female sex [odds ratio (OR): 2.05, .01], hypertension (OR: 2.10, .04) previous 1.35, .04).ConclusionMedium term results following are comparable, regardless characteristics.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (19)
CITATIONS (12)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....